<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bandaram Pharma Packtech Ltd has filed its annual disclosure with BSE confirming that it does not qualify as a 'Large Corporate' under SEBI's October 2023 circular (SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172). The disclosure covers the 2-year block period of FY 2025-26 and FY 2026-27. The company states that mandatory borrowing through debt securities is 'Not Applicable' and actual borrowing done through debt securities in FY 2025-26 is Nil. No shortfall or penalty applies for the current or previous block. The filing was signed by Chairman and Managing Director B. Deepak Reddy on April 30, 2026.
This is a routine regulatory filing with no material impact on shareholders. It simply confirms the company falls outside SEBI's Large Corporate classification, meaning no mandatory debt-security borrowing or related penalties apply.